摘要
目的观察前列地尔(前列腺素E1脂微球载体制剂,PGE1)与低分子肝素钙(LMWH)治疗不稳定型心绞痛(UAP)的临床疗效及不良反应。方法将28例UAP患者随机分成2组,治疗组(17例)给予PGE1加LMWH;对照组(11例)给予LMWH治疗,2组均给予口服阿司匹林和抗心绞痛药物,疗程均为10天。结果治疗组与对照组在住院10天内治疗总有效率分别为94.1%与72.7%(P<0.05),2组均未出现不良反应。结论在常规治疗基础上PGE1加LMWH治疗UAP能更有效地控制心绞痛发作。
Objective To observe the efficacy and ARDs of alprostadil (Lipo-prostaglandin E1, Lipo PGE1) plus low molecular weight heparin (LMWH) for treatment of unstable angina pectoris(UAP).Methods 28 patients with UAP were randomly divided to receive alprostadil plus LMWH (n=17) for 10d or LMWH (n=11) for10d, inaddition to aspirin and antianginal agents. Results The total effective rate for active and control group was 94.1%and 72.7% respectively (P< 0.05).No ARDs were observed in both groups. Conclusion The alp...
出处
《当代医学》
2008年第20期169-170,共2页
Contemporary Medicine
关键词
前列地尔
低分子肝素钙
不稳定型心绞痛
alprostadil
Lipo PGE1
low molecular weight heparin
unstable angina pectoris
